MY166063A - Intravenous antiviral treatments - Google Patents
Intravenous antiviral treatmentsInfo
- Publication number
- MY166063A MY166063A MYPI20083086A MYPI20083086A MY166063A MY 166063 A MY166063 A MY 166063A MY PI20083086 A MYPI20083086 A MY PI20083086A MY PI20083086 A MYPI20083086 A MY PI20083086A MY 166063 A MY166063 A MY 166063A
- Authority
- MY
- Malaysia
- Prior art keywords
- antiviral treatments
- intravenous
- intravenous antiviral
- treatments
- kits
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77274806P | 2006-02-13 | 2006-02-13 | |
| PCT/US2006/013535 WO2007117241A1 (en) | 2006-04-12 | 2006-04-12 | Intramuscular antiviral treatments |
| PCT/US2007/003755 WO2007095218A1 (en) | 2006-02-13 | 2007-02-12 | Intravenous antiviral treatments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY166063A true MY166063A (en) | 2018-05-23 |
Family
ID=38169715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20083086A MY166063A (en) | 2006-02-13 | 2008-08-13 | Intravenous antiviral treatments |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1986626A1 (ja) |
| JP (3) | JP2009538822A (ja) |
| KR (9) | KR20160129105A (ja) |
| AU (2) | AU2007215156A1 (ja) |
| BR (1) | BRPI0707769A2 (ja) |
| CA (1) | CA2642260C (ja) |
| EA (1) | EA025483B1 (ja) |
| HK (1) | HK1212250A1 (ja) |
| MX (2) | MX2008010394A (ja) |
| MY (1) | MY166063A (ja) |
| WO (1) | WO2007095218A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1986626A1 (en) * | 2006-02-13 | 2008-11-05 | Biocryst Pharmaceuticals Inc. | Intravenous antiviral treatments |
| CN101367750B (zh) * | 2007-08-14 | 2012-05-23 | 中国人民解放军军事医学科学院毒物药物研究所 | (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途 |
| KR20220033561A (ko) | 2020-09-07 | 2022-03-17 | 주식회사 경보제약 | 페라미비르 화합물을 포함하는 프리믹스 제형의 제약학적 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT933993E (pt) * | 1996-06-14 | 2006-10-31 | Biocryst Pharm Inc | Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase |
| DE69840674D1 (de) * | 1997-12-17 | 2009-04-30 | Biocryst Pharm Inc | Substituierte cyclopentan- und cyclopenten-verbindungen als neuraminidase-blocker |
| GB0015324D0 (en) * | 2000-06-22 | 2000-08-16 | Biota Scient Management | Medicaments |
| EP1986626A1 (en) * | 2006-02-13 | 2008-11-05 | Biocryst Pharmaceuticals Inc. | Intravenous antiviral treatments |
-
2007
- 2007-02-12 EP EP07750583A patent/EP1986626A1/en not_active Ceased
- 2007-02-12 JP JP2008554421A patent/JP2009538822A/ja not_active Withdrawn
- 2007-02-12 KR KR1020167030296A patent/KR20160129105A/ko not_active Application Discontinuation
- 2007-02-12 AU AU2007215156A patent/AU2007215156A1/en not_active Abandoned
- 2007-02-12 KR KR20147030611A patent/KR20140132778A/ko not_active Application Discontinuation
- 2007-02-12 KR KR1020087022406A patent/KR20080096829A/ko active Application Filing
- 2007-02-12 BR BRPI0707769-6A patent/BRPI0707769A2/pt not_active Application Discontinuation
- 2007-02-12 KR KR1020197017311A patent/KR102194015B1/ko active IP Right Grant
- 2007-02-12 KR KR1020217018500A patent/KR102323339B1/ko active IP Right Grant
- 2007-02-12 CA CA2642260A patent/CA2642260C/en active Active
- 2007-02-12 KR KR1020207036259A patent/KR102267754B1/ko active IP Right Grant
- 2007-02-12 MX MX2008010394A patent/MX2008010394A/es active IP Right Grant
- 2007-02-12 KR KR1020187005451A patent/KR101992585B1/ko active IP Right Review Request
- 2007-02-12 EA EA200870263A patent/EA025483B1/ru unknown
- 2007-02-12 MX MX2020002008A patent/MX2020002008A/es unknown
- 2007-02-12 KR KR1020227042429A patent/KR20230003248A/ko not_active Application Discontinuation
- 2007-02-12 KR KR1020217035812A patent/KR102475176B1/ko active IP Right Grant
- 2007-02-12 WO PCT/US2007/003755 patent/WO2007095218A1/en active Application Filing
-
2008
- 2008-08-13 MY MYPI20083086A patent/MY166063A/en unknown
-
2013
- 2013-08-14 AU AU2013216632A patent/AU2013216632B2/en active Active
- 2013-08-26 JP JP2013174479A patent/JP6073202B2/ja active Active
-
2015
- 2015-07-09 JP JP2015137495A patent/JP2015180695A/ja not_active Withdrawn
-
2016
- 2016-01-14 HK HK16100369.5A patent/HK1212250A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6073202B2 (ja) | 2017-02-01 |
| KR20160129105A (ko) | 2016-11-08 |
| KR20210076189A (ko) | 2021-06-23 |
| JP2015180695A (ja) | 2015-10-15 |
| JP2009538822A (ja) | 2009-11-12 |
| KR102475176B1 (ko) | 2022-12-07 |
| KR102267754B1 (ko) | 2021-06-23 |
| MX2020002008A (es) | 2020-07-13 |
| WO2007095218A1 (en) | 2007-08-23 |
| EA025483B1 (ru) | 2016-12-30 |
| KR20190072681A (ko) | 2019-06-25 |
| KR101992585B9 (ko) | 2022-09-20 |
| KR20230003248A (ko) | 2023-01-05 |
| EP1986626A1 (en) | 2008-11-05 |
| CA2642260C (en) | 2016-08-09 |
| KR102323339B1 (ko) | 2021-11-08 |
| MX2008010394A (es) | 2009-01-12 |
| AU2013216632A1 (en) | 2013-08-29 |
| AU2013216632B2 (en) | 2016-09-01 |
| KR20140132778A (ko) | 2014-11-18 |
| KR20180024027A (ko) | 2018-03-07 |
| EA200870263A1 (ru) | 2009-06-30 |
| CA2642260A1 (en) | 2007-08-23 |
| KR20200143519A (ko) | 2020-12-23 |
| AU2007215156A1 (en) | 2007-08-23 |
| KR20080096829A (ko) | 2008-11-03 |
| JP2013256527A (ja) | 2013-12-26 |
| KR20210135632A (ko) | 2021-11-15 |
| BRPI0707769A2 (pt) | 2011-05-10 |
| KR101992585B1 (ko) | 2019-06-25 |
| HK1212250A1 (en) | 2016-06-10 |
| KR102194015B1 (ko) | 2020-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122522T1 (el) | Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος | |
| MX2010002318A (es) | Derivados azaindol 2,3-sustituidos para tratar infecciones virales. | |
| MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
| MX2009009761A (es) | Composiciones y estuches para tratamiento de la influenza. | |
| WO2009105513A3 (en) | Novel compounds and methods for therapy | |
| WO2008127364A3 (en) | Antiviral compounds and use thereof | |
| MX2009008617A (es) | Uso de antagonistas de interleucina-23 para el tratamiento de infeccion. | |
| MX360301B (es) | Moleculas pequeñas que contienen boro como agentes antiinflamatorios. | |
| UA118645C2 (uk) | Спосіб комбінованої терапії раку наночастинками, що містять рапаміцин і альбумін | |
| WO2009149179A3 (en) | Enhanced antiviral therapy methods and devices | |
| MX354099B (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
| MX2009011533A (es) | Productos quimicos, composiciones y metodos para tratamiento y prevencion de infecciones de virus orthopox y enfermedades asociadas. | |
| WO2008115281A3 (en) | Compounds for treating viral infections | |
| TNSN08400A1 (en) | Organic compounds and their uses | |
| EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
| MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| MX2008015775A (es) | Compuestos y composiciones para tratamiento de cancer. | |
| MXPA04006572A (es) | Terapia de combinacion antivirica. | |
| TN2011000204A1 (en) | Cycloundecadepsipeptide compounds and use of said compounds as a medicament | |
| MX2007008158A (es) | Tratamiento de trastornos por el virus de hepatitis c. | |
| TNSN08496A1 (en) | Aminothiazoles and their uses | |
| MX2009012767A (es) | Metodos de tratamiento de infecciones fungicas. | |
| MX2009009693A (es) | Metodos para activar irs-1 y akt. | |
| WO2007132355A3 (en) | Compositions and methods for inhibiting viral adhesion | |
| MY166063A (en) | Intravenous antiviral treatments |